Overweight and obesity are increasing worldwide. In general practice, different approaches exist to treat people with weight problems. To provide the foundation for the development of a structured clinical pathway for overweight and obesity management in primary care, we performed a systematic overview of international evidence-based guidelines. We searched in PubMed and major guideline databases for all guidelines published in World Health Organization (WHO) "Stratum A" nations that dealt with adults with overweight or obesity. Nineteen guidelines including 711 relevant recommendations were identified. Most of them concluded that a multidisciplinary team should treat overweight and obesity as a chronic disease. Body mass index (BMI) should be used as a routine measure for diagnosis, and weight-related complications should be taken into account. A multifactorial, comprehensive lifestyle programme that includes reduced calorie intake, increased physical activity, and measures to support behavioural change for at least 6 to 12 months is recommended.
percentage points in the average BMI of a society reduces average life expectancy by 1 year. 7 Numerous interventions can be recommended to people with overweight or obesity, such as dietary modifications, physical activity, behavioural changes, pharmacological treatment, and bariatric surgery. General practitioners and multidisciplinary support teams play a crucial role in helping patients achieve sustainable weight loss. 8 Patients trust the advice of primary care providers on weight management, but various barriers hinder the effective counselling and treatment of patients with overweight or obesity.
On the one hand, physicians and other health professionals often lack training in the behavioural counselling and interdisciplinary team work that is necessary for a comprehensive lifestyle intervention and often have negative attitudes towards people with obesity. 9 On the other hand, overweight and obesity is not only determined by lifestyle but also by hereditary factors. This often discourages the appropriate implementation of effective evidencebased interventions. 10, 11 Difficulties changing behaviour on a lasting basis may also explain the limited extent to which such interventions are implemented. One underlying reason for this may be the longterm increase in hunger-stimulating hormones that follows significant weight loss, 12 combined with continuous exposure to an obesogenic environment and its multiple and continuous temptations. 13 It is therefore essential to carefully select evidence-based interventions when treating people with overweight or obesity in primary care. A wide range of treatment options is available, but the level of agreement between evidence-based clinical guidelines on how best to manage patients with overweight or obesity is unclear. To provide the foundation for the development of a structured and evidence-based clinical pathway for overweight and obesity management in primary care, we therefore performed a systematic overview of international evidence-based guidelines and recommendations. PubMed and the guideline databases, with the exception of NGC, which was closed in July 2018. We used a combination of Medical subject heading (MeSH) terms and text words for obesity and overweight as search terms. Details of the searches can be found as electronic supplementary materials in the appendix.
| Selection process
Guidelines had to fulfil all of the following criteria to be included in our systematic overview: 
| Quality assessment
The methodological quality of all included guidelines was assessed using the validated guideline appraisal tool of the Appraisal of Guidelines for Research and Evaluation Collaboration (AGREE II). 15, 16 The instrument consists of 23 items grouped into six domains (scope and purpose [three items], stakeholder involvement [three items], rigour of development [eight items], clarity of presentation [three items], applicability [four items], and editorial Independence [two items]) and one overall assessment item. Two reviewers with experience in guideline quality assessment appraised each guideline independently. Each item was rated on a 7-point Likert scale ranging from 1 point (strong disagreement) to 7 points (strong agreement). In accordance with the AGREE II manual, scaled domain scores were calculated by summing up the scores assigned by the individual appraisers to the items in each of the six domains, and by calculating the total as a percentage of the maximum possible score for each domain. Overall guideline quality was also rated on a 7-point Likert scale ranging from 1 point (lowest possible quality) to 7 points (highest possible quality), taking into account the previously evaluated individual items and the resulting domain scores. Guidelines were then ranked on the basis of their overall assessment scores. Since the AGREE II instrument does not provide a specific cut-off to distinguish between high-and low-quality guidelines, its users often apply a cut-off based on either the domain scores or overall guideline quality. 17 For this overview, guidelines with overall assessment scores greater than or equal to 6 points were rated as high quality, those with 4 to 5.9 points as moderate quality, and those with less than 4 points as low quality.
| Data extraction
To characterize the guidelines, we extracted information on the topic of the guideline, the publishing society, country of origin, publication date, and the number of recommendations.
All clearly identifiable recommendations that were considered relevant to general practitioners were extracted from the included guidelines, along with their respective grades of recommendation (GoR) where indicated. We only included recommendations that could be used in individual patient management and excluded general recommendations directed at the health care system as a whole, eg, public health strategies. Recommendations that explicitly addressed children and adolescents were also excluded. In order to enable the different approaches taken by the guidelines to grade the strength of their recommendations to be compared (eg, AACEguidelines use the letter "A" to mark strong recommendations, while NICE guidelines use words like "must" and "should" to reflect them), we developed a standardized GoR system for this overview that is based on the different approaches described in the methodological sections of the respective guidelines (GoR "A" for strong, GoR "B" for moderate, GoR "C" for weak, GoR "D" for very weak recommendations, and "EC" for expert consensus).
To provide a structured evidence-based systematic overview of international guidelines, two authors grouped the recommendations by topic and compared them with each other. It was thus possible to assess guideline recommendations for consistency and to compare them with one another with reference to the AGREE II scores in the source guidelines. of them, we included three publications on two additional guidelines, [18] [19] [20] and two updates 21, 22 of guidelines identified in the 2016 search. [23] [24] [25] [26] Overall, 31 publications describing 19 current guide- 
| Characteristics and quality of included guidelines
Of the 19 included guidelines, two were published in 2018, 20,21 two in 2016, 18, 19, 22 three in 2015, 38, 40, 50, 51 six in 2014, [30] [31] [32] [33] [34] [35] [36] [37] 39, [47] [48] [49] 52 five in 2013, [27] [28] [29] [43] [44] [45] [46] and one in 2012. 41, 42 In 13 guidelines, the target population consisted of adults only, while the remaining six guidelines dealt with people of all ages. 20, 22, [44] [45] [46] [47] [48] 50, 51 The guidelines were developed and issued by institutions in the United States (n = 10), 18, 19, 21, 22, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 40, 43, 52 the United Kingdom (n = 3), [47] [48] [49] [50] [51] Germany (n = 2), 20, 39 Canada (n = 1), 38 Australia (n = 1), 46 Spain (n = 1), 41, 42 and by a European medical society (n = 1). 44, 45 Nine of the included FIGURE 1 Flow chart of guideline selection process guidelines addressed all subject areas relating to the management of overweight and obesity. 18, 19, 22, [30] [31] [32] [33] [34] [35] [36] 38, 39, 43, [46] [47] [48] 52 The remaining 10 guidelines dealt with dietary interventions (n = 3), 28, 29, 37, 41, 42 bariatric surgery (n = 3), 20, 27, 44, 45 lifestyle interventions (n = 2), 21,49 pharmacological weight reduction (n = 1), 40 and obesity prevention (n = 1). 50, 51 Details on the characteristics of the included guidelines can be found in Table 1 . Table 2 shows the AGREE II domain scores and overall assessment scores for each guideline. The mean overall assessment score for the methodological quality of the guidelines was 4.7 out of a maximum of 7 points (SD 1.5), as assessed using the AGREE II instrument. According to the classifications used in this overview, five guidelines were of high quality, 20, 21, [30] [31] [32] [33] [34] [35] [36] 38, 46 nine of moderate quality, 18, 19, 27, 39, [41] [42] [43] [47] [48] [49] [50] [51] [52] and the remaining five of low quality. 22, 28, 29, 37, 40, 44, 45 The highest overall rating was assigned to the overweight and obesity management guideline developed by the Australian National Health and Medical Research Council (NHMRC). 46 The methodological quality of the obesity prevention and management guideline published by the University of Michigan (UoM) was rated lowest. 22 An examination of the different AGREE II domains revealed that most of the guidelines achieved high scores in "Scope and Purpose," which aims to analyse to what extent the guidelines' objectives, the disease itself, and the target population are described, and in "Clarity of Presentation," which evaluates the clarity and ease of identification of recommendations. Only three guidelines attained 50% or less of the maximum possible score in Scope and Purpose 22, 40, 44, 45 and only two achieved 50% or less in Clarity of Presentation. 22, 44, 45 The mean score for these two domains was 76.6%. The AGREE II domain with the lowest scores was "Applicability," which describes facilitators and barriers to the application of the guidelines as well as potential resource implications and monitoring criteria. Only two guidelines achieved more than 50% of the maximum in this domain. 46, 50, 51 On the other hand, five guidelines provided no information on applicability at all. 18, 19, [40] [41] [42] 44, 45, 52 The mean score for this domain was 27%.
In total, 711 relevant recommendations were identified in the 19 guidelines. The number of recommendations extracted from each guideline ranged from 165 from one of the bariatric surgery guidelines 27 to only one recommendation from the US Preventive Task Force 2018 (USPTF) guideline on behavioural weight loss interventions. 21 Almost half the recommendations (n = 313; 44%) were classified as strong, which corresponds to a standardized GoR of A, while 132 were moderate and allocated a standardized GoR of B (19%), and 102 weak and received a C (14%). Sixteen recommendations were designated very weak, corresponding to a standardized GoR of D (2%).
The remaining 148 recommendations (21%) were based on EC. In 15 guidelines, the level of evidence (LoE) for the underlying studies was specified in addition to the GoR. The LoEs rank studies according to the probability of bias. Systematic reviews of RCTs and high-quality
RCTs are usually assigned the highest level, while case reports and expert opinions are ranked lowest. 53 The three guidelines from NICE reported only GoRs, [47] [48] [49] [50] [51] while one guideline (International Federation for the Surgery of Obesity [IFSO]) only provided LoEs. 44, 45 According to the methodology section of the IFSO guideline, LoE corresponds to recommendation strength. Underlying evidence could be clearly assigned to individual recommendations in only a few guidelines.
In the guideline synopsis, the extracted recommendations on the management of overweight and obesity were summarized and allocated to one of nine groups, depending on topic. Table 3 provides an overview of the topics covered by recommendations in each of the included guidelines. An overview of key guideline recommendations for overweight and obesity management can be found in Table 4 . Further important recommendations on the nine topics are summarized below, together with their GoR in the individual guidelines.
| Summary of recommendations

| General recommendations
According to the nine guidelines covering the topic, 18, 19, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 39, 41, 42, [47] [48] [49] 52 
| Weight-related complications and other comorbidities
Weight-related complications and other comorbidities and/or risk factors were mentioned in five guidelines 18, 19, 22, 39, 40, 47, 48 and are consid- Recommendations on lifestyle interventions aimed at maintaining a healthy weight were found in six guidelines. 28, 29, 37, 39, [46] [47] [48] 52 It was noted that after weight reduction, long-term measures to maintain Recommendations on specific behavioural interventions were found in eleven guidelines. 18, 19, 21, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] 43, [46] [47] [48] 52 These guidelines 
| Pharmacological weight-reduction
In seven guidelines, 18, 19, [38] [39] [40] [46] [47] [48] 52 
| Bariatric surgery
Eleven guidelines recommend undertaking bariatric surgery, [18] [19] [20] 22, 27, [30] [31] [32] [33] [34] [35] [36] 39, 40, [44] [45] [46] [47] [48] 52 which is a treatment option in adults with a BMI greater than or equal to 40 kg/m 2 or a BMI greater than or equal 4.1 | Key findings (see also A multifactorial, comprehensive lifestyle programme that includes a reduction in calorie intake, an increase in physical activity, and Overweight and obesity should be managed by a multidisciplinary team.
BMI should be used as a routine measure for diagnosis.
BMI ≥25 to <30 kg/m 2 is associated with increased risk of cardiovascular disease, and BMI ≥30 kg/m 2 with increased risk of cardiovascular disease and mortality.
Waist circumference should be used as an additional measure to assess the risk of developing obesity-related long-term health problems.
A multifactorial, comprehensive lifestyle intervention for at least 6 to 12 months that includes a reduction in calorie intake, an increase in physical activity, and measures to support behavioural change, is essential in the treatment of overweight and obesity. 
| Overweight and obesity in primary care
Overweight and obesity are complex conditions and maintaining weight loss over the long term is one of the biggest challenges in overweight and obesity management. In this context, one key factor, which is addressed in nearly all guidelines, is the adoption of a multicomponent and multidisciplinary approach. Recent research has indicated that comprehensive programmes administered by multiprofessional teams are required for success. 54, 55 In addition, a qualitative study investigating the beliefs, skills, and knowledge of involved researchers, practitioners, and patients reported that close multidisciplinary collaboration and knowledge about the role of each participant in the management process, combined with continuous monitoring, may contribute towards treatment success. 56 The aim of this project was to provide a clear and systematic 57 Another review concluded that studies performed in primary care provide little evidence on the effectiveness of overweight and obesity management and that further research is needed to define the role of primary care providers in the context of comprehensive and multi-professional care. 58 As most trials are performed in specialist obesity clinics and research centres, trials in primary care and information on long-term health outcomes are only available to a limited degree. [59] [60] [61] Based on our review, we were therefore unable to clearly define which components of obesity management should be delivered in which healthcare setting, not least because of differences in healthcare systems themselves.
Nevertheless, research on the importance of primary care has shown that countries with a highly developed primary care sector that is both comprehensive and coordinates its activities with other medical professionals achieve better population health outcomes and reduced socio-economic health inequalities, both in the Organisation for Economic Co-operation and Development (OECD) 62 and the European Union. 63 To develop clinical pathways, we relied mainly on strong recommendations extracted from the included guidelines, treatment algorithms identified during the search of other guidelines, and the webpages of relevant associations.
Further details are described in the full report of the Main Association of Austrian Social Security Institutions. 64 
| Strengths and limitations
The strengths of this overview were the inclusion of all 19 current evidence-based guidelines that could be identified using a comprehensive search strategy. Another strength was the high number of recommendations classified as strong. Out of a total of 711 identified recommendations, 44% were classified as strong (corresponding to a standardized GoR of A) and a further 19% were classified as moderate (corresponding to a standardized GoR of B). A further strength is the high degree of agreement between individual publishing associations and the groups of authors responsible for preparing the guidelines, ie, there were no contradictory recommendations. Current guidelines on hypertension, for example, show that this is not always the case.
Based on the same evidence, the European Society of Cardiology (ESC) guideline 65 Limitations of this study were the sole inclusion of guidelines from high-income WHO Stratum A countries and the exclusion of guidelines that were not in English or German. The included guidelines therefore only reflected conditions in high-income countries. Additionally, more than half of them came from the United States, where the healthcare system has different characteristics to those in other high-income countries. Although only evidence-based guidelines were included and many of the specific recommendations were classified as strong, the methodological quality (based on an AGREE II assessment) of the included guidelines was only moderate in most of them. The low quality of the included guidelines in the AGREE II domain applicability made it difficult to draw conclusions on the clinical implementability of recommendations. In most cases, the guidelines did not address supporting factors and barriers to applications and provided no specific tools to enable recommendations to be put into practice. As it may not be possible to directly transfer results from one population group to another, a further limitation to applicability is that recommended BMI cut-points did not take different ethnic groups and national health systems into account.
| CONCLUSIONS
To the best of our knowledge, this is the first time a structured systematic overview of international guidelines has been performed that includes all subjects relating to overweight and obesity management.
These range from general recommendations, diagnoses, and assessments to the various treatment options. The 19 identified evidencebased guidelines included 711 distinct recommendations and there were no relevant discrepancies between them. Thus there is considerable international agreement on how best to define a multidisciplinary clinical pathway for the management of overweight and obesity in primary care in high-income countries.
